Get the Stockscreener App
14.96
5.42%
0.76
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $14.96, with a volume of 139.45K.
It is up +5.42% in the last 24 hours and up +9.51% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$14.20
Open:
$14.04
24h Volume:
139.45K
Relative Volume:
0.32
Market Cap:
$649.56M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-26.71
EPS:
-0.56
Net Cash Flow:
$-20.63M
1W Performance:
+7.23%
1M Performance:
+9.51%
6M Performance:
+158.55%
1Y Performance:
+270.54%
1-Day Range:
$13.95
$14.98
1-Week Range:
$13.70
$14.98
52-Week Range:
$3.92
$15.23
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen Inc (AXGN) Shares Up 3.84% on Nov 4 - GuruFocus.com
AxoGen (AXGN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
When (AXGN) Moves Investors should Listen - Stock Traders Daily
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Semanteon Capital Management LP Acquires New Position in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 - GlobeNewswire
Axogen (STU:LT3) Cyclically Adjusted PS Ratio : 4.57 (As of Oct. 23, 2024) - GuruFocus.com
South Korea Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
Colombia Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
nVerses Capital LLC Acquires Shares of 4,000 AxoGen, Inc. (NASDAQ:AXGN) - Defense World
(AXGN) Investment Analysis - Stock Traders Daily
FY2028 EPS Estimates for AxoGen Cut by Leerink Partnrs - Defense World
AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains? - MSN
Axogen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic? - Simply Wall St
Leerink Partnrs Has Weak Outlook for AxoGen FY2028 Earnings - MarketBeat
AxoGen (NASDAQ:AXGN) Stock Price Down 4.3%Should You Sell? - MarketBeat
Exchange Traded Concepts LLC Reduces Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen stock soars to 52-week high, hits $15.12 amid robust gains - Investing.com Australia
Axogen stock soars to 52-week high, hits $15.12 amid robust gains By Investing.com - Investing.com South Africa
StockNews.com Upgrades AxoGen (NASDAQ:AXGN) to “Buy” - Defense World
AxoGen (NASDAQ:AXGN) Rating Increased to Buy at StockNews.com - MarketBeat
Peripheral Nerves Injury Operative A Game Changer for Global Finance Forecast-Neurorrhaphy, Nerve Grafting, Axogen, Inte – IndiaPolitics.com - IndiaPolitics.com
Peripheral Nerve Injuries Therapeutic Market Business Standards – AxoGen, Inc., Stryker, Baxter International - Cauverynews
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Millennium Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Stake Cut by Millennium Management LLC - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Decline in Short Interest - MarketBeat
AxoGen (NASDAQ:AXGN) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Squarepoint Ops LLC Has $441,000 Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... - Yahoo Finance
(AXGN) Trading Report - Stock Traders Daily
Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63% - Yahoo Finance
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors - Benzinga
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Hsbc Holdings PLC - Defense World
AxoGen (NASDAQ:AXGN) Upgraded to "Buy" at StockNews.com - MarketBeat
AxoGen (NASDAQ:AXGN) Upgraded to “Buy” at StockNews.com - Defense World
Cubist Systematic Strategies LLC Sells 29,134 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Is AxoGen Poised For A Rebound? - RTTNews
AxoGen (NASDAQ:AXGN) Trading Down 5.9% - MarketBeat
Axogen Inc (AXGN) Trading Down 3.61% on Oct 3 - GuruFocus.com
Axogen Inc. (AXGN) expanding its growth trajectory ahead - SETE News
Perceptive Advisors LLC Lowers Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Perceptive Advisors LLC - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 17.7% in September - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Sees Large Drop in Short Interest - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Buy" by Analysts - MarketBeat
Wall Street SWOT: AxoGen stock shows promise amid leadership change and strong Q2 - Investing.com
Rhumbline Advisers Increases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen (NASDAQ:AXGN) Stock Rating Upgraded by StockNews.com - MarketBeat
AxoGen (NASDAQ:AXGN) Upgraded by StockNews.com to Buy - Defense World
First Light Asset Management LLC Purchases 2,578,147 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):